Sandoz Partner Gan & Lee Wraps Phase III Insulin Glargine Trial

Follows Earlier Positive Phase I Clinal Data For Biosimilar Rival To Lantus

 
• By Dean Rudge
  
Diabetes; Chalkboard on a wooden background
Gan & Lee And Sandoz Have Been Partners Since Late 2018 • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products